A phase I trial of IW-1973 for the treatment of cardiovascular diseases

Trial Profile

A phase I trial of IW-1973 for the treatment of cardiovascular diseases

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs IW 1973 (Primary)
  • Indications Cardiovascular disorders; Pulmonary arterial hypertension
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 18 Feb 2016 According to an Ironwood Pharmaceuticals media release, the company announced positive data of IW-1973 for the treatment of cardiovascular disorders.
    • 18 Feb 2016 Status changed from recruiting to completed, according to an Ironwood Pharmaceuticals media release,
    • 11 Jan 2016 According to an Ironwood Pharmaceuticals media release, results from this study are expected in 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top